Lamivudine therapy in renal allograft recipients with hepatitis B virus infection

Transplant Proc. 2003 Feb;35(1):278-9. doi: 10.1016/s0041-1345(02)03850-2.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Female
  • Hepatitis B / drug therapy*
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B virus / isolation & purification
  • Hepatitis B virus / physiology
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Kidney Transplantation / physiology*
  • Lamivudine / therapeutic use*
  • Male
  • Postoperative Complications / virology
  • Recurrence
  • Retrospective Studies
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Virus Activation

Substances

  • Antiviral Agents
  • Hepatitis B Surface Antigens
  • Immunosuppressive Agents
  • Reverse Transcriptase Inhibitors
  • Lamivudine